Literature DB >> 9341215

Site-specific phosphorylation of the human immunodeficiency virus type-1 Rev protein accelerates formation of an efficient RNA-binding conformation.

D E Fouts1, H L True, K A Cengel, D W Celander.   

Abstract

Phosphorylation is important in the regulation of many cellular processes, yet the precise role of protein phosphorylation for many RNA-binding protein substrates remains obscure. In this report, we demonstrate that phosphorylation of a recombinant human immunodeficiency virus type-1 Rev protein promotes rapid formation of an efficient RNA-binding state. The apparent dissociation constant for ligand binding is enhanced 7-fold for the protein following phosphorylation; however, phosphate addition leads to a 1. 6-fold decrease in RNA ligand-protein complex stability. RNA ligand binding stimulates slow formation of an equally competent binding state for the unphosphorylated protein, indicating that the addition of phosphate or ligand binding promotes a similar conformational change in Rev. Phosphorylation directly alters the conformation of Rev, as revealed by modification experiments that monitor the solvent accessibility of cysteines in the protein. These biochemical properties are attributed to the addition of phosphate at one of two serine residues (Ser-54 or Ser-56) that lie within the multimerization domain adjacent to the RNA-binding helix. Glutaraldehyde-mediated cross-linking experiments revealed that phosphorylation of Rev does not affect Rev multimerization activity. The Rev protein from the less pathogenic HIV-2 isolate lacks this phosphorylation site in the amino acid sequence; thus, the described biochemical properties of the phosphorylated protein may contribute to Rev activity and possibly to HIV-1 virulence during natural infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341215     DOI: 10.1021/bi971551d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element.

Authors:  S B Buonomo; A Michienzi; F G De Angelis; I Bozzoni
Journal:  RNA       Date:  1999-08       Impact factor: 4.942

2.  Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.

Authors:  Souad Naji; Géza Ambrus; Peter Cimermančič; Jason R Reyes; Jeffrey R Johnson; Rebecca Filbrandt; Michael D Huber; Paul Vesely; Nevan J Krogan; John R Yates; Andrew C Saphire; Larry Gerace
Journal:  Mol Cell Proteomics       Date:  2011-12-15       Impact factor: 5.911

3.  Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance.

Authors:  Hongying Chen; Andrew Gill; Brian K Dove; Stevan R Emmett; C Fred Kemp; Mark A Ritchie; Michael Dee; Julian A Hiscox
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology.

Authors:  Sheila A Barber; Linda Bruett; Brian R Douglass; David S Herbst; M Christine Zink; Janice E Clements
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.

Authors:  Y S Nam; A Petrovic; K S Jeong; S Venkatesan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function.

Authors:  M Narayan; K Kusuhara; P L Green
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Heroin-Induces Differential Protein Expression by Normal Human Astrocytes (NHA).

Authors:  Jessica L Reynolds; Supriya D Mahajan; Donald Sykes; Madhavan P N Nair
Journal:  Am J Infect Dis       Date:  2006

8.  ICP27 phosphorylation site mutants are defective in herpes simplex virus 1 replication and gene expression.

Authors:  Santos Rojas; Kara A Corbin-Lickfett; Laurimar Escudero-Paunetto; Rozanne M Sandri-Goldin
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

9.  Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.

Authors:  Deidra Shuck-Lee; Fei Fei Chen; Ryan Willard; Sharmila Raman; Roger Ptak; Marie-Louise Hammarskjold; David Rekosh
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

10.  Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design?

Authors:  Tulio de Oliveira; Marco Salemi; Michelle Gordon; Anne-Mieke Vandamme; Estrelita Janse van Rensburg; Susan Engelbrecht; Hoosen M Coovadia; Sharon Cassol
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.